Skip to main content

Eli Lilly & Co

No ongoing recalls currently shown

Based on the official records currently available to Public Health Trace, no recalls naming Eli Lilly & Co are currently shown as ongoing. The 1 record below is a historical recall record.

Public Health Trace has 1 recall naming Eli Lilly & Co as the recalling firm, republished from official FDA and USDA sources.

Recall history - 1 terminated record

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20181
Download CSV

FDA Recall TerminatedTerminated: April 22, 2020Historical recordClass III

ERBITUX CETUXIMAB Injection, 200 mg/100 mL (2 mg/mL), 100 mL per single-use vial, Rx only, Manufactured by: ImClone LLC, a wholly-owned subsidiary of Eli Lilly and Company, Branchburg, NJ 08876 USA. NDC: 66733-958-23

by Eli Lilly & Co

Reason
Labeling: Missing label; potential for missing primary container label on the vial.
Published
November 21, 2018
Distribution
AL, AZ, CA, KS, LA, MS, OH, OR, TN, TX a…

View recall →

Showing 1–1 of 1 results

Some FDA recall records on this page come from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.

This page lists recalls that name Eli Lilly & Co as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.